What is NDC 59651-241?

59651-241 is the product NDC for Imatinib Mesylate, Imatinib mesylate 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.

Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Imatinib Mesylate?

39 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Imatinib Mesylate NDC 59651-241 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)59651-241Labeler and product segments. Claims need a package NDC.

Product NDC at billing width59651-0241Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
59651-241-03	59651024103	3 BLISTER PACK in 1 CARTON (59651-241-03) / 10 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Jul 23, 2020
59651-241-30	59651024130	30 TABLET, FILM COATED in 1 BOTTLE (59651-241-30)Marketed from Jul 23, 2020

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Imatinib Mesylate
Generic name (nonproprietary): imatinib mesylate
Active ingredients: Imatinib mesylate — 400 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Aurobindo Pharma LimitedNDC labeler code 59651
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212773
Marketing start: Jul 23, 2020
Listing expires: Dec 31, 2027
Other FDA classes: Bcr-Abl Tyrosine Kinase Inhibitors (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)
Identifiers: Product ID 59651-241_d00eefc8-50ef-494f-bcae-5b19329a9c7bSPL ID d00eefc8-50ef-494f-bcae-5b19329a9c7bSPL set ID a4e409f7-20b4-4c80-8a6a-f95995ffad78RxCUI 403878, 403879UNII 8A1O1M485BUPC 0359651240908, 0359651241301
Pharmacologic class: Kinase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N459651024103 followed by a unit qualifier and the quantity

Package 59651-0241-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 28, 2026.

Indications (excerpt from the label)

Imatinib mesylate is a kinase inhibitor indicated for the treatment of: Newly diagnosed adult and pediatric patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in chronic phase. (1.1) Patients with Philadelphia chromosome positive chronic myeloid leukemia (Ph+ CML) in blast crisis (BC), accelerated phase (AP), or in chronic phase (CP) after failure of interferon-alpha therapy. ( 1.2 ) Adult patients with relapsed or refractory Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL). (1.3) Pediatric patients with newly diagnosed Philadelphia chromosome positive acute lymphoblastic leukemia (Ph+ ALL) in combination with chemotherapy. ( 1.4 ) Adult …

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 59651-241

What is NDC 59651-241?: 59651-241 is the product NDC for Imatinib Mesylate, Imatinib mesylate 400 mg/1 tablet, film coated, listed with the FDA by Aurobindo Pharma Limited. It has 2 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Imatinib Mesylate.
What is the active ingredient?: Imatinib mesylate.
Who is the labeler?: Aurobindo Pharma Limited, NDC labeler code 59651. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Imatinib Mesylate?: 39 other product NDCs are listed under this name. See all Imatinib Mesylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Imatinib Mesylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	Civica Script LLC	82249-020	82249-0020-90
Imatinib Mesylate	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	Civica Script LLC	82249-021	82249-0021-30
Imatinib Mesylateimatinib	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	Safecor Health, LLC	48433-049	48433-0049-03
Imatinib Mesylateimatinib	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	Safecor Health, LLC	48433-050	48433-0050-03
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-296	31722-0296-90
Imatinib Mesylate	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	Camber Pharmaceuticals, Inc.	31722-297	31722-0297-30
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	American Health Packaging	60687-882	60687-0882-21
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-622	68001-0622-05
Imatinib Mesylate	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-623	68001-0623-04
imatinib mesylate	Imatinib mesylate 100 mg/1	TabletOral	Upsher-Smith Laboratories, LLC	0832-0532	00832-0532-09

All 40 Imatinib Mesylate NDCs

Other NDCs under ANDA 212773

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212773
Product	Strength	Form · route	Labeler	Product NDC
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-622
Imatinib Mesylate	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	BluePoint Laboratories	68001-623
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	Aurobindo Pharma Limited	59651-240
Imatinib Mesylate	Imatinib mesylate 100 mg/1	Tablet, Film coatedOral	QUALLENT PHARMACEUTICALS HEALTH LLC	82009-086
Imatinib Mesylate	Imatinib mesylate 400 mg/1	Tablet, Film coatedOral	QUALLENT PHARMACEUTICALS HEALTH LLC	82009-087